Haigh, J.E.; Rack, S.; Yan, R.; Babu, S.; Donnelly, O.; Walter, H.; Faust, G.; Bhagani, S.; Isola, P.; Metcalf, R.
Evaluation of Clinical Parameters Associated with Response and Resistance to Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma: A Multi-Institutional Retrospective Cohort Study. Curr. Oncol. 2025, 32, 168.
https://doi.org/10.3390/curroncol32030168
AMA Style
Haigh JE, Rack S, Yan R, Babu S, Donnelly O, Walter H, Faust G, Bhagani S, Isola P, Metcalf R.
Evaluation of Clinical Parameters Associated with Response and Resistance to Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma: A Multi-Institutional Retrospective Cohort Study. Current Oncology. 2025; 32(3):168.
https://doi.org/10.3390/curroncol32030168
Chicago/Turabian Style
Haigh, Joseph Edward, Sam Rack, Ruiyang Yan, Sherin Babu, Olly Donnelly, Harriet Walter, Guy Faust, Shradha Bhagani, Patrick Isola, and Robert Metcalf.
2025. "Evaluation of Clinical Parameters Associated with Response and Resistance to Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma: A Multi-Institutional Retrospective Cohort Study" Current Oncology 32, no. 3: 168.
https://doi.org/10.3390/curroncol32030168
APA Style
Haigh, J. E., Rack, S., Yan, R., Babu, S., Donnelly, O., Walter, H., Faust, G., Bhagani, S., Isola, P., & Metcalf, R.
(2025). Evaluation of Clinical Parameters Associated with Response and Resistance to Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma: A Multi-Institutional Retrospective Cohort Study. Current Oncology, 32(3), 168.
https://doi.org/10.3390/curroncol32030168
